Thiazolidinediones News and Research

RSS
Thiazolidinediones are adjunctive therapies for diabetes mellitus (type 2) and related diseases.
Short-term use of DPP-4 inhibitors does not increase risk for pancreatic cancer

Short-term use of DPP-4 inhibitors does not increase risk for pancreatic cancer

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Study explores new ways to improve medications to treat type 2 diabetes

Study explores new ways to improve medications to treat type 2 diabetes

Novo Nordisk launches insulin delivery device NovoPen Echo in the U.S.

Novo Nordisk launches insulin delivery device NovoPen Echo in the U.S.

DPP-4 inhibitors may reduce risk of autoimmune diseases

DPP-4 inhibitors may reduce risk of autoimmune diseases

Combinations of sEH inhibition and PPARγ activation have beneficial effects on cardiometabolic syndrome

Combinations of sEH inhibition and PPARγ activation have beneficial effects on cardiometabolic syndrome

Study describes pharmacological action of TZDs directly on pancreas

Study describes pharmacological action of TZDs directly on pancreas

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Common diabetes treatment may cause bladder cancer

Common diabetes treatment may cause bladder cancer

Abscisic acid has anti-inflammatory effects in the lungs and gut

Abscisic acid has anti-inflammatory effects in the lungs and gut

Diabetes drug raises bladder cancer risk

Diabetes drug raises bladder cancer risk

Pioglitazone may raise bladder cancer risk

Pioglitazone may raise bladder cancer risk

Pioglitazone may raise bladder cancer risk

Pioglitazone may raise bladder cancer risk

Thiazolidinedione drugs linked with increased risk of DME in patients with Type 2 diabetes

Thiazolidinedione drugs linked with increased risk of DME in patients with Type 2 diabetes

Researchers identify new mitochondrial protein complex linked with type 2 diabetes

Researchers identify new mitochondrial protein complex linked with type 2 diabetes

Increased risk of bladder cancer linked to diabetes drug

Increased risk of bladder cancer linked to diabetes drug

NCoR deficiency may pump up muscles and prevent diabetes

NCoR deficiency may pump up muscles and prevent diabetes

Byetta combination with insulin glargine gets FDA nod in type 2 diabetes

Byetta combination with insulin glargine gets FDA nod in type 2 diabetes

Researchers create powerful anti-diabetic prototype drugs with lesser side effects

Researchers create powerful anti-diabetic prototype drugs with lesser side effects

Takeda resubmits alogliptin and fixed-dose combination therapy NDA to FDA

Takeda resubmits alogliptin and fixed-dose combination therapy NDA to FDA